FINDY
Product Code:
AG-CR1-3662
AG-CR1-3662
Regulatory Status:
RUO
RUO
Shipping:
-20°C
-20°C
Storage:
Short Term: +4°C. Long Term: -20°C
Short Term: +4°C. Long Term: -20°C
No additional charges, what you see is what you pay! *
| Code | Size | Price |
|---|
| AG-CR1-3662-M001 | 1 mg | £60.00 |
Quantity:
| AG-CR1-3662-M005 | 5 mg | £210.00 |
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: Switzerland.
Typical lead time: 7-10 working days.
Contact us for more accurate information.
Typical lead time: 7-10 working days.
Contact us for more accurate information.
- Further Information
- Documents
- References
- Related Products
- Show All
Further Information
Alternate Names/Synonyms:
(Z)-5-(4-Methoxy-3-((trimethylsilyl)ethynyl)benzylidene)-2-thioxothiazolidin-4-one
Appearance:
Light to dark yellow solid.
CAS:
1507367-37-4
EClass:
32160000
Form (Short):
liquid
Handling Advice:
Keep cool and dry.Protect from light and moisture.
InChi:
InChI=1S/C16H17NO2S2Si/c1-19-13-6-5-11(9-12(13)7-8-22(2,3)4)10-14-15(18)17-16(20)21-14/h5-6,9-10H,1-4H3,(H,17,18,20)/b14-10-
InChiKey:
JHFDWHHUUUMRLK-UVTDQMKNSA-N
Long Description:
Chemical. CAS: 1507367-37-4. Formula: C16H17NO2S2Si. MW: 347.5. Synthetic. Suppressor of DYKR1A intramolecular Ser97 autophosphorylation. Cell permeable thioxothiazolidinone derivative that specifically targets newly synthesized cellular DYRK1A, but not DYRK1B or DYRK2, for proteasomal degradation by suppressing DYKR1A intramolecular Ser97 autophosphorylation, a necessary event for folding/maturation of newly translated DYRK1A. Highly selective inhibitor for DYKR1A over other DYRK family members. Unlike INDY and other ATP-competitive DYRK inhibitors, ineffective against the kinase activity of DYRK1A, DYRK1B, DYRK2 or DYRK3 (IC50>10µM). Inhibits only GSK3beta, MARK4, PIM1, PIM3, PLK3 by over 75% at 10µM among a panel of 271 kinases. Selectively rescues the developmental defect of Xenopus embryos induced by the overexpression of DYRK1A, but not DYRK1B.
MDL:
MFCD30718582
Molecular Formula:
C16H17NO2S2Si
Molecular Weight:
347.5
Package Type:
Plastic Vial
Product Description:
Suppressor of DYKR1A intramolecular Ser97 autophosphorylation. Cell permeable thioxothiazolidinone derivative that specifically targets newly synthesized cellular DYRK1A, but not DYRK1B or DYRK2, for proteasomal degradation by suppressing DYKR1A intramolecular Ser97 autophosphorylation, a necessary event for folding/maturation of newly translated DYRK1A. Highly selective inhibitor for DYKR1A over other DYRK family members. Unlike INDY and other ATP-competitive DYRK inhibitors, ineffective against the kinase activity of DYRK1A, DYRK1B, DYRK2 or DYRK3 (IC50>10µM). Inhibits only GSK3beta, MARK4, PIM1, PIM3, PLK3 by over 75% at 10µM among a panel of 271 kinases. Selectively rescues the developmental defect of Xenopus embryos induced by the overexpression of DYRK1A, but not DYRK1B.
Purity:
>98% (HPLC)
SMILES:
O=C1NC(S/C1=CC2=CC=C(OC)C(C#C[Si](C)(C)C)=C2)=S
Solubility Chemicals:
Soluble in DMSO (25mg/ml).
Transportation:
Non-hazardous
UNSPSC Category:
Protein Kinase Modulators
UNSPSC Number:
12352200
Use & Stability:
Stable for at least 2 years after receipt when stored at -20°C.
Documents
References
Selective inhibition of the kinase DYRK1A by targeting its folding process: I. Kii, et al.; Nat. Commun. 7, 11391 (2016)